Scienture Holdings, Inc. is selling 3,225,000 shares of common stock at $1.20 per share to institutional investors, raising around $3.9 million in gross proceeds. The offering is set to close on August 15, 2025. The funds will be used to develop and distribute specialty pharmaceutical products. SCNX is currently trading at $1.22 on NasdaqCM, down 45.0450%. This move aims to support the company’s efforts in addressing unmet market needs.

Read more at Nasdaq: Scienture Secures $3.9 Mln Through Registered Direct Stock Offering